| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dicrotophos |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Dicrotophos inhibits the expression of DME GSTA1 |
[1] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01119
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME GSTA1 |
[2] |
| 3-methylpyridine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01140
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
3-methylpyridine inhibits the drug-metabolizing activity of DME GSTA1 |
[3] |
| Chlorpyrifos |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01248
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Chlorpyrifos induces the drug-metabolizing activity of DME GSTA1 |
[4] |
| Kaempferol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01353
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Kaempferol up-regulates the expression of DME GSTA1 |
[5] |
| Okadaic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01409
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Okadaic acid inhibits the expression of DME GSTA1 |
[6] |
| Usnic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01497
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Usnic acid induces the drug-metabolizing activity of DME GSTA1 |
[7] |
| Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Dinophysistoxin 1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00813
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Biotoxin |
| DME Modulation |
Dinophysistoxin 1 inhibits the expression of DME GSTA1 |
[8] |
| Azaspiracid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01502
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Marine Algal Toxin |
| DME Modulation |
Azaspiracid inhibits the expression of DME GSTA1 |
[8] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene inhibits the expression of DME GSTA1 |
[9], [10] |
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate up-regulates the expression of DME GSTA1 |
[11] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME GSTA1 |
[12], [13] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Polychlorinated dibenzodioxin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00917
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Polychlorinated dibenzodioxin up-regulates the expression of DME GSTA1 |
[14] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Alpha-linolenic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00873
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Alpha-linolenic acid up-regulates the expression of DME GSTA1 |
[15] |
| Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME GSTA1 |
[16] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution inhibits the expression of DME GSTA1 |
[17] |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
| Arachidoyl-coenzyme A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00901
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Arachidoyl-coenzyme A inhibits the drug-metabolizing activity of DME GSTA1 |
[18] |
| Bilirubin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00877
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Bilirubin up-regulates the expression of DME GSTA1 |
[19] |
| Estradiol 3,17-disulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00912
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Estradiol 3,17-disulfate inhibits the drug-metabolizing activity of DME GSTA1 |
[20] |
| Lauroyl-coenzyme A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00902
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Lauroyl-coenzyme A inhibits the drug-metabolizing activity of DME GSTA1 |
[18] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 22 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen up-regulates the expression of DME GSTA1 |
[21] |
| Aemcolo |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00421
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Aemcolo up-regulates the expression of DME GSTA1 |
[22] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide up-regulates the expression of DME GSTA1 |
[23], [24] |
| Carbamazepine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00011
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Carbamazepine up-regulates the expression of DME GSTA1 |
[25] |
| Chlorambucil |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00014
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Chlorambucil inhibits the drug-metabolizing activity of DME GSTA1 |
[26] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME GSTA1 |
[27] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME GSTA1 |
[28] |
| Dexamethasone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dexamethasone induces the drug-metabolizing activity of DME GSTA1 |
[29] |
| Diclofenac |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00352
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Diclof DMEenac inhibits the drug-metabolizing activity of DME GSTA1 |
[30] |
| Dopamine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00290
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dopamine hydrochloride inhibits the drug-metabolizing activity of DME GSTA1 |
[31] |
| Estradiol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol inhibits the expression of DME GSTA1 |
[32] |
| Hydrocortisone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00264
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydrocortisone up-regulates the expression of DME GSTA1 and leads to increasing the drug-metabolizing activity of this enzyme |
[33] |
| Ketoconazole |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ketoconazole inhibits the expression of DME GSTA1 |
[34] |
| Methotrexate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Methotrexate up-regulates the expression of DME GSTA1 |
[35] |
| Mifepristone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00127
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Mifepristone induces the drug-metabolizing activity of DME GSTA1 |
[36] |
| Phenobarbital |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00410
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Phenobarbital inhibits the drug-metabolizing activity of DME GSTA1 |
[37] |
| Phenytoin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00232
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Phenytoin up-regulates the expression of DME GSTA1 |
[19] |
| Rifampin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00223
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Rifampin induces the drug-metabolizing activity of DME GSTA1 |
[38] |
| Urethane |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Urethane inhibits the expression of DME GSTA1 |
[39] |
| Artemisinine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00449
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Artemisinine inhibits the drug-metabolizing activity of DME GSTA1 |
[40] |
| Benzoic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00447
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Benzoic acid induces the drug-metabolizing activity of DME GSTA1 |
[41] |
| Linoleic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01367
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Linoleic acid up-regulates the expression of DME GSTA1 |
[15] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| SGX301 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00579
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
SGX301 inhibits the drug-metabolizing activity of DME GSTA1 |
[42] |
| Sulforafan |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01478
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Sulforafan induces the drug-metabolizing activity of DME GSTA1 |
[43] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| MeIQx |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00609
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MeIQx inhibits the expression of DME GSTA1 |
[2], [44] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Quercetin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin inhibits the drug-metabolizing activity of DME GSTA1 |
[45] |
| Xanthohumol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00636
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Xanthohumol inhibits the expression of DME GSTA1 |
[46] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Oleoyl-coenzyme A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01413
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
Oleoyl-coenzyme A inhibits the expression of DME GSTA1 |
[6] |
| Eugenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00885
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
Eugenol inhibits the drug-metabolizing activity of DME GSTA1 |
[47] |
| K-7174 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
K-7174 inhibits the expression of DME GSTA1 |
[48] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Beta-naphthoflavone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Beta-naphthoflavone inhibits the expression of DME GSTA1 |
[49] |
| Other Chemical Compound(s) or Element(s) |
| Food Additive |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 4-propylphenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00929
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Food Additive |
| DME Modulation |
4-propylphenol inhibits the drug-metabolizing activity of DME GSTA1 |
[47] |
| Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Picolines |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01020
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Chemical Compound |
| DME Modulation |
Picolines inhibits the expression of DME GSTA1 |
[50] |
| Tungsten |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00793
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Chemical Compound |
| DME Modulation |
Tungsten up-regulates the expression of DME GSTA1 |
[51] |
|
|
|
|
|
|